+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

From
From
From
Multiple Sclerosis - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Multiple Sclerosis - Global Clinical Trials Review, 2025

  • Clinical Trials
  • June 2025
  • Global
From
From
Myasthenia Gravis: Opportunity Assessment and Forecast - Product Thumbnail Image

Myasthenia Gravis: Opportunity Assessment and Forecast

  • Report
  • June 2025
  • 85 Pages
  • Global
From
Multiple Sclerosis: Epidemiology Forecast to 2034 - Product Thumbnail Image

Multiple Sclerosis: Epidemiology Forecast to 2034

  • Report
  • June 2025
  • 33 Pages
  • Global
From
From
From
Mucopolysaccharidosis II (Hunter Syndrome): Market View - Product Thumbnail Image

Mucopolysaccharidosis II (Hunter Syndrome): Market View

  • Report
  • May 2025
  • 80 Pages
  • Global
From
From
Hypoglycemia - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Hypoglycemia - Global Clinical Trials Review, 2025

  • Clinical Trials
  • May 2025
  • 252 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more